CHOLAHLDNG Cholamandalam Financial Holdings Q3 FY25 results (Oct–Dec 2024) and concall
Cholamandalam Financial Holdings reported robust premium growth in Q3 FY25, outperforming the industry. The company saw an improved claims ratio and maintained strong solvency. However, health loss ratios deteriorated, and management acknowledged challenges with EoM compliance due to new accounting norms, indicating a cautious approach to high-cost channels.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 29 | 3 |
| EBITDA | 4,553 | 4,718 |
| Net profit | 24 | 2 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
